Off-Label Use of Drugs and Medical Devices: A Review of Policy Implications
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference40 articles.
1. Off-label Prescribing Among Office-Based Physicians
2. Depression treatment during outpatient visits by U.S. children and adolescents
3. Regulating Off-Label Drug Use — Rethinking the Role of the FDA
4. U.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Optimizing therapeutic decision‐making for off‐label medicines use: A scoping review and consensus recommendations for improving practice and research+;Pharmacoepidemiology and Drug Safety;2023-06-21
2. Toward Uniform Insurer Coverage for Functional MRI Following Severe Brain Injury;Journal of Head Trauma Rehabilitation;2023-02-28
3. Turning Neural Prosthetics Into Viable Products;Frontiers in Robotics and AI;2021-09-29
4. Biocell-Initial patents versus user instructions guide: A discrepancy at the core of a crisis;Annales de Chirurgie Plastique Esthétique;2021-08
5. Off-Label Use of Medicines: A Comparative Study on the Regulation of Medicinal Products in Selected European Union Member States;European Journal of Risk Regulation;2020-12-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3